0001140361-21-021495.txt : 20210617
0001140361-21-021495.hdr.sgml : 20210617
20210617190349
ACCESSION NUMBER: 0001140361-21-021495
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210617
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SYKES RICHARD
CENTRAL INDEX KEY: 0001372810
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 211026458
MAIL ADDRESS:
STREET 1: C/O PDS BIOTECHNOLOGY CORPORATION
STREET 2: 25B VREELAND ROAD
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
FORM 4
X0306
4
2021-06-17
0001472091
PDS Biotechnology Corp
PDSB
0001372810
SYKES RICHARD
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD
FLORHAM PARK
NJ
07932
true
Stock Option (Right to Buy)
9.95
2021-06-17
4
A
0
9000
0
A
2031-06-17
Common Stock
9000
9000
D
The Stock Option will vest in full and become fully exercisable on June 17, 2022.
/s/ Hillary Yegen, attorney-in-fact
2021-06-17